Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Collegium Pharmaceutical Inc. (COLL)

20.23   0.53 (2.69%) 09-20 01:08
Open: 19.89 Pre. Close: 19.7
High: 20.32 Low: 19.41
Volume: 567,599 Market Cap: 698M
Collegium Pharmaceutical, Inc. operates as a pharmaceutical company, which engages in the developing and planning to commercialize next generation, abuse-deterrent products for the treatment of patients suffering from chronic pain and other diseases. The company is headquartered in Stoughton, Massachusetts and currently employs 266 full-time employees. The firm is engaged in developing and commercializing abuse-deterrent products that incorporate its DETERx platform technology for the treatment of chronic pain and other diseases. Its products include Xtampza ER and ONSOLIS. Its DETERx platform provides extended-release drug delivery, while safeguarding against common methods of abuse and tampering, including crushing, chewing, and heating and injecting. Xtampza ER is designed to provide adequate pain control while maintaining its extended-release drug release profile after being subjected to common methods of abuse and accidental misuse. ONSOLIS is a Transmucosal Immediate-Release Fentanyl (TIRF) film indicated for the management of breakthrough pain in cancer patients (BTPc), 18 years of age and older, who are already receiving and who are tolerant to opioid therapy for their underlying persistent cancer pain.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 20.332 - 20.392 20.392 - 20.46
Low: 19.231 - 19.303 19.303 - 19.383
Close: 20.099 - 20.211 20.211 - 20.337

Technical analysis

as of: 2020-09-18 4:29:29 PM
Overall:       
Stoxline posted a BUY today, same as yesterday. Upward movement continues.
Target: Six months: 23.87     One year: 27.88
Support: Support1: 18.56    Support2: 17.40
Resistance: Resistance1: 20.44    Resistance2: 23.87
Pivot: 19.02
Moving Average: MA(5): 19.39     MA(20): 18.83
MA(100): 18.82     MA(250): 18.56
MACD: MACD(12,26): 0.36     Signal(9): 0.27
Stochastic oscillator: %K(14,3): 77.39     %D(3): 64.86
RSI: RSI(14): 62.81
52-week: High: 25.59  Low: 10.43  Change(%): 78.9
Average Vol(K): 3-Month: 35068  10-Days: 26682

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.
COLL has closed below upper band by 7.3%. Bollinger Bands are 15.2% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Mon, 14 Sep 2020
Collegium Announces Five Posters Presented at PAINWeek 2020 National Conference - GlobeNewswire

Sat, 05 Sep 2020
Collegium Pharmaceutical Inc (NASDAQ:COLL) Expected to Announce Quarterly Sales of $77.84 Million - MarketBeat

Fri, 04 Sep 2020
Collegium Pharmaceutical (COLL) Gets a Buy Rating from Needham - Smarter Analyst

Fri, 04 Sep 2020
Is Collegium Pharmaceutical Inc (COLL) the Top Pick in the Drug Manufacturers - Specialty & Generic Industry? - InvestorsObserver

Wed, 02 Sep 2020
Collegium Pharmaceutical Inc. (COLL) Soars 5.77% on September 02 - Equities.com

Mon, 31 Aug 2020
Are Investors Undervaluing Collegium Pharmaceutical, Inc. (NASDAQ:COLL) By 28%? - Simply Wall St

Financial Analysis

Growth
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Price to Book Value: Outperform Discounted cash flow: Outperform
Return on Assets: Neutral Price to Earnings: Outperform
Return on Equity: Neutral Debt to Equity: Outperform
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Drug Manufacturers General Specialty & Generic
Shares Out. (M) 35
Shares Float (M) 28
% Held by Insiders 2.00
% Held by Institutions 106.74
Shares Short (K) 4,100
Shares Short P. Month (K) 4,180

Stock Financials

EPS
EPS Est This Year -3.000
EPS Est Next Year -1.880
Book Value (p.s.) 4.520
Profit Margin 0.07
Operating Margin 4.26
Return on Assets (ttm) 1.7
Return on Equity (ttm) 0.2
Qtrly Rev. Growth 4.0
Gross Profit (p.s.) 2.984
Sales Per Share 8.738
EBITDA (p.s.) 1.393
Qtrly Earnings Growth
Operating Cash Flow (M) 59
Levered Free Cash Flow (M) -317

Stock Valuations

PE Ratio
PEG Ratio
Price to Book value 4.48
Price to Sales 2.32
Price to Cash Flow 11.86

Stock Dividends

Dividend
Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
android_stock_chart
Stock Chart
stoxline_lite
Stoxline Lite
stoxline_pro
Stoxline Pro
Option_Calculator
Option Calculator
(c) 2006-2020 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.